These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 28777835)
1. Effect of Methotrexate on an In Vitro Patient-Derived Model of Proliferative Vitreoretinopathy. Amarnani D; Machuca-Parra AI; Wong LL; Marko CK; Stefater JA; Stryjewski TP; Eliott D; Arboleda-Velasquez JF; Kim LA Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):3940-3949. PubMed ID: 28777835 [TBL] [Abstract][Full Text] [Related]
2. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy. Huang L; Xu Y; Yu W; Li Y; Chu L; Dong J; Li X Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3193-204. PubMed ID: 20071679 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Effect of Everolimus on Retinal Pigment Epithelial Cells and Experimental Proliferative Vitreoretinopathy. Kuo HK; Chen YH; Kuo YH; Ke MC; Tseng YC; Wu PC Curr Eye Res; 2018 Mar; 43(3):333-339. PubMed ID: 29182404 [TBL] [Abstract][Full Text] [Related]
4. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF. Hollborn M; Tenckhoff S; Jahn K; Iandiev I; Biedermann B; Schnurrbusch UE; Limb GA; Reichenbach A; Wolf S; Wiedemann P; Kohen L; Bringmann A Mol Vis; 2005 Jun; 11():397-413. PubMed ID: 15988409 [TBL] [Abstract][Full Text] [Related]
5. Epithelial Membrane Protein-2 in Human Proliferative Vitreoretinopathy and Epiretinal Membranes. Telander DG; Yu AK; Forward KI; Morales SA; Morse LS; Park SS; Gordon LK Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3112-7. PubMed ID: 27294805 [TBL] [Abstract][Full Text] [Related]
6. Assessment of the integrin alpha5beta1 antagonist JSM6427 in proliferative vitreoretinopathy using in vitro assays and a rabbit model of retinal detachment. Zahn G; Volk K; Lewis GP; Vossmeyer D; Stragies R; Heier JS; Daniel PE; Adamis AP; Chapin EA; Fisher SK; Holz FG; Löffler KU; Knolle J Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1028-35. PubMed ID: 19815730 [TBL] [Abstract][Full Text] [Related]
7. Pathological vitreous causes cell line-derived (but not donor-derived) retinal pigment epithelial cells to display proliferative vitreoretinopathy-like features in culture. Sharma M; Tiwari A; Sharma S; Bansal R; Gupta V; Gupta A; Luthra-Guptasarma M Clin Exp Ophthalmol; 2014 Nov; 42(8):745-60. PubMed ID: 24612444 [TBL] [Abstract][Full Text] [Related]
9. Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration. Oberstein SY; Byun J; Herrera D; Chapin EA; Fisher SK; Lewis GP Mol Vis; 2011; 17():1794-805. PubMed ID: 21750605 [TBL] [Abstract][Full Text] [Related]
10. P38 inhibition reverses TGFβ1 and TNFα-induced contraction in a model of proliferative vitreoretinopathy. Schiff L; Boles NC; Fernandes M; Nachmani B; Gentile R; Blenkinsop TA Commun Biol; 2019; 2():162. PubMed ID: 31069271 [TBL] [Abstract][Full Text] [Related]
11. Vitreous M2 Macrophage-Derived Microparticles Promote RPE Cell Proliferation and Migration in Traumatic Proliferative Vitreoretinopathy. Song Y; Liao M; Zhao X; Han H; Dong X; Wang X; Du M; Yan H Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):26. PubMed ID: 34554178 [TBL] [Abstract][Full Text] [Related]
12. Resveratrol inhibits epithelial-mesenchymal transition of retinal pigment epithelium and development of proliferative vitreoretinopathy. Ishikawa K; He S; Terasaki H; Nazari H; Zhang H; Spee C; Kannan R; Hinton DR Sci Rep; 2015 Nov; 5():16386. PubMed ID: 26552368 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of extracellular matrix components in epiretinal membranes of vitreoproliferative retinopathy and proliferative diabetic retinopathy. Ioachim E; Stefaniotou M; Gorezis S; Tsanou E; Psilas K; Agnantis NJ Eur J Ophthalmol; 2005; 15(3):384-91. PubMed ID: 15945009 [TBL] [Abstract][Full Text] [Related]
14. Idelalisib inhibits vitreous-induced Akt activation and proliferation of retinal pigment epithelial cells from epiretinal membranes. Xin T; Han H; Wu W; Huang X; Cui J; Matsubara JA; Song J; Wang F; Colyer M; Lei H Exp Eye Res; 2020 Jan; 190():107884. PubMed ID: 31786159 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive circular RNA profiling of proliferative vitreoretinopathy and its clinical significance. Yao J; Hu LL; Li XM; Shan K; Zhou RM; Ge HM; Yao MD; Jiang Q; Zhao C; Yan B Biomed Pharmacother; 2019 Mar; 111():548-554. PubMed ID: 30597308 [TBL] [Abstract][Full Text] [Related]
16. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells. Casaroli-Marano RP; Pagan R; Vilaró S Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2062-72. PubMed ID: 10440262 [TBL] [Abstract][Full Text] [Related]
17. Activation of neural progenitor cells in human eyes with proliferative vitreoretinopathy. Johnsen EO; Frøen RC; Albert R; Omdal BK; Sarang Z; Berta A; Nicolaissen B; Petrovski G; Moe MC Exp Eye Res; 2012 May; 98():28-36. PubMed ID: 22465407 [TBL] [Abstract][Full Text] [Related]
18. Trichostatin A Inhibits Retinal Pigmented Epithelium Activation in an In Vitro Model of Proliferative Vitreoretinopathy. Por ED; Greene WA; Burke TA; Wang HC J Ocul Pharmacol Ther; 2016 Sep; 32(7):415-24. PubMed ID: 27494828 [TBL] [Abstract][Full Text] [Related]
19. Induction of proliferative vitreoretinopathy by a unique line of human retinal pigment epithelial cells. Wong CA; Potter MJ; Cui JZ; Chang TS; Ma P; Maberley AL; Ross WH; White VA; Samad A; Jia W; Hornan D; Matsubara JA Can J Ophthalmol; 2002 Jun; 37(4):211-20. PubMed ID: 12095094 [TBL] [Abstract][Full Text] [Related]
20. [Periostin in the Pathogenesis of Proliferative Vitreoretinopathy]. Ishikawa K Nippon Ganka Gakkai Zasshi; 2015 Nov; 119(11):772-80. PubMed ID: 26685481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]